← Mechanisms of action
KLRK1
SINGLE PROTEINHomo sapiens
Preferred name: NKG2-D type II integral membrane protein
Linked proteins
Drugs acting on this target (17)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| allogeneic cart-nkg2d cells | Immunity, passive | experimental | Cell therapy | KLRK1 immunity, passive |
| car-nk cells targeting nkg2d ligands | Immunity, passive | experimental | Cell therapy | immunity, passive - KLRK1 |
| cccr-nk92 cells | Immunity, passive | experimental | Cell therapy | immunity, passive - NKG2D |
| cd8+nkg2d+ akt cell | Immunity, passive | experimental | Cell therapy | immunity, passive - KLRK1 |
| cm-cs1 t-cell | Immunity, passive | experimental | Cell therapy | immunity, passive - nkg2d |
| cyad-02 | Immunity, passive | experimental | Cell therapy | immunity, passive - NKG2D |
| cyad-101 | Immunity, passive | experimental | Cell therapy | immunity, passive - NKG2D |
| kd-025 car-t cells | Immunity, passive | experimental | Cell therapy | immunity, passive - NKG2D |
| nkg2d car-nk | Immunity, passive | experimental | Cell therapy | immunity, passive - KLRK1 |
| nkg2d car-t cell | Immunity, passive | experimental | Cell therapy | immunity, passive - KLRK1 |
| nkg2d-car-nk92 cells | Immunity, passive | experimental | Cell therapy | immunity, passive - KLRK1 |
| nkg2dl-targetting chimeric antigen receptor-grafted gamma delta t cell | Immunity, passive | experimental | Cell therapy | immunity, passive - KLRK1 |
| nkr-2 car-t cells | Immunity, passive | experimental | Cell therapy | immunity, passive - NKG2D |
| nkx101 | Immunity, passive | experimental | Cell therapy | immunity, passive - NKG2D |
| nnc 0070-0002-0349 | Immunity, passive | experimental | Cell therapy | immunity, passive - NKG2D |
| jnj-64304500 | Inhibitor | experimental | mAb | KLRK1 inhibitor |
| nnc0142-0002 | Inhibitor | experimental | mAb | KLRK1 inhibitor |